Chronic pain after herniorraphy pregabalin versus placebo.

Trial Profile

Chronic pain after herniorraphy pregabalin versus placebo.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by NTr record.
    • 23 Sep 2009 Lead trial centre and sponsor (Pfizer) added as reported by Netherlands Trial Register.
    • 23 Sep 2009 New source identified and integrated Netherlands Trial Register record).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top